mgrosva@gmail.com
Since emergence and wide spread dissemination of SARS- COV-2 all efforts in the scientific community have been focused on understanding the pathophysiology of the disease, alongside all aspects of a global health problem and its complexities. More over the scientific community is trying to accelerate the velocity of knowledge dissemination beyond that of the virus transcontinental sweep over by various strategies of fast track, green open access and preprints. At the same time, we must try to avoid any enticement for exoneration in accuracy and methodological soundness of the studies.
In this paper we try to raise either a new or under noticed medication for this disease based on an in-press accepted manuscript of senior author of this manuscript and some other independent researchers.(1-3)